Loading clinical trials...
Loading clinical trials...
Patients diagnosed with arrested pre-term labor following tocolytics at 24-34 gestational weeks will be randomly allocated to receive either vaginal micronized progesterone 400 mg/day or no treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HaEmek Medical Center, Israel
NCT07015203 · Preeclampsia (PE), Fetal Growth Restriction, and more
NCT01829204 · Vulvodynia, Mycoses, and more
NCT04821544 · Postpartum Depression, Preterm Labor
NCT06968364 · Threatened Preterm Labor
NCT06794307 · Preterm Birth, Hyperglycemia, and more
Poriya Medical Center
Tiberias, North
Emek Medical center
Afula, Please Select
Assuta Ashdod medical center
Ashdod
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions